Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIODESIX INC Director's Dealing 2026

Jan 27, 2026

34472_dirs_2026-01-27_ae8a3dd9-2d55-4044-9971-f507956bdb9f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2026-01-23

Reporting Person: SCHULER JACK W (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-01-23 Common Stock P 80000 $11.8084 Acquired 1543210 Indirect
2026-01-26 Common Stock P 20000 $11.8032 Acquired 1563210 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 750000 Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.225 to $12.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

F3: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.56 to $11.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F4: Jack W. Schuler is the sole trustee of the Jack W. Schuler 2025 GRAT.